Sayour, Alex Ali <br/><br/>
Acute canagliflozin treatment protects against in vivo myocardial ischemia-reperfusion injury in non-diabetic male rats and enhances endothelium-dependent vasorelaxation.  [electronic resource] 

 -  Journal of translational medicine  04 2019 
 - 127 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1479-5876 
<br/><br/><label>Standard No.: </label>10.1186/s12967-019-1881-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aldehydes--metabolism<br/>Animals<br/>Aorta--drug effects<br/>Apoptosis--drug effects<br/>Biomarkers--metabolism<br/>Blood Glucose--metabolism<br/>Canagliflozin--pharmacology<br/>Cardiotonic Agents--pharmacology<br/>Diastole--drug effects<br/>Endothelium--drug effects<br/>Glycosuria--complications<br/>Kidney--drug effects<br/>Liver--drug effects<br/>Male<br/>Myocardial Reperfusion Injury--complications<br/>Nitrosative Stress--drug effects<br/>Oxidative Stress--drug effects<br/>Phosphorylation--drug effects<br/>Rats, Sprague-Dawley<br/>Signal Transduction--drug effects<br/>Systole--drug effects<br/>Vasodilation--drug effects<br/>Ventricular Function, Left--drug effects